Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diatide Research Laboratories

Division of Bayer AG
www.diatide.com

Latest From Diatide Research Laboratories

Schering: Building Franchises

Germany's Schering AG is betting it can crack the US market using a franchise of smaller products, rather than relying on a single blockbuster. It reckons this strategy--which few have used before--is best suited to its size and strengths.
Medical Device Strategy

Good News for a Small-Cap Imaging Company

Schering AG's purchase of Diatide Inc. appears to be an exception to the general rule that, while small-cap acquisitions are at an all-time high, the shareholders of acquired companies don't fare particularly well. Schering areed to pay a significant premium over the the Diatide stock price just prior to the deal, despite the fact that Nycomed Amersham PLC owns partial rights to Diatides two late-stage products. Schering was willing to pay the price because of its commitment to developing a franchise in nuclear imaging.
BioPharmaceutical Medical Device

Angstrom Pharmaceuticals Inc.

Structure-based design of small-molecule, non-toxic, angiogenesis inhibitor drugs for treating cancer
BioPharmaceutical Research and Development Strategies
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register